GlassScriptPhysician profile
Kenson Lo
NPI 1245301407
$1,155.86
in general payments reported to CMS, 2019-2025
21 companies · $421 in 2025
The $421 reported for 2025 was more than what 91% of Pediatrics providers received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $90.12 · 2020: $29.05 · 2021: $97.80 · 2022: $148 · 2023: $116 · 2024: $254 · 2025: $421.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $791.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $791.13 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi Pasteur INC. | $117.60 | 2022-2025 | |
| Merck Sharp & Dohme LLC | $111.06 | 2023-2025 | Vaxneuvance, Vaxelis, Gardasil 9 |
| Supernus Pharmaceuticals, INC. | $100.43 | 2022-2025 | |
| Abbvie INC. | $87.96 | 2024-2025 | |
| Cranial Technologies, INC | $85.81 | 2021-2025 | Doc Band |
| Glaxosmithkline, LLC. | $84.83 | 2020-2025 | Bexsero |
| Alk-Abello, INC | $81.07 | 2025 | Neffy |
| Kaleo, INC. | $78.15 | 2019-2023 | Auvi-Q |
| Pfizer INC. | $64.07 | 2025 | |
| Tris Pharma INC | $43.91 | 2022-2024 | Quillivant |
| Takeda Pharmaceuticals U.S.A., INC. | $43.25 | 2019-2021 | |
| Collegium Pharmaceutical, INC. | $42.79 | 2025 | Jornay Pm |
| Sanofi-Aventis U.S. LLC | $39.26 | 2024 | |
| Neos Therapeutics, LP | $34.59 | 2019 | |
| Adlon Therapeutics L.P. | $33.20 | 2021 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ironshore Pharmaceuticals INC. | $24.50 | 2022 | |
| Aytu Biopharma, INC. | $21.55 | 2025 | |
| Kowa Pharmaceuticals America, INC. | $20.44 | 2025 | Zoryve |
| Verrica Pharmaceuticals INC. | $16.93 | 2025 | Ycanth |
| Cumberland Pharmaceuticals, INC. | $12.36 | 2021 | |
| Mission Pharmacal Company | $12.10 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kenson Lo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.